These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12907499)

  • 21. Clarifying conflict of interest.
    Brody H
    Am J Bioeth; 2011 Jan; 11(1):23-8. PubMed ID: 21240802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. US Senate committee investigates conflicts of interest in industry funded medical education.
    Tanne JH
    BMJ; 2009 Aug; 339():b3139. PubMed ID: 19654162
    [No Abstract]   [Full Text] [Related]  

  • 23. Conflict of interest in the physician interface with the biomedical industry.
    Minnigan H; Chisholm CD
    Emerg Med Clin North Am; 2006 Aug; 24(3):671-85. PubMed ID: 16877136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Answering Brody's challenge from a pharmapologist perspective.
    Harter TD
    Am J Bioeth; 2011 Jan; 11(1):29-30. PubMed ID: 21240803
    [No Abstract]   [Full Text] [Related]  

  • 25. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Money for drugs: should physicians be paid for pharmaceutical development and clinical investigations?
    Van Way C; Bohigian G; Gale A; Powell M; Hagan JC
    Mo Med; 2011; 108(5):320-9. PubMed ID: 22073488
    [No Abstract]   [Full Text] [Related]  

  • 27. Beyond a pejorative understanding of conflict of interest.
    Williams-Jones B
    Am J Bioeth; 2011 Jan; 11(1):1-2. PubMed ID: 21240793
    [No Abstract]   [Full Text] [Related]  

  • 28. The dos and don'ts of collaborating with industry.
    Moynihan R
    BMJ; 2012 May; 344():e3247. PubMed ID: 22569871
    [No Abstract]   [Full Text] [Related]  

  • 29. Physician-industry interactions: there is no such thing as a free lunch.
    Tsai HJ
    Taiwan J Obstet Gynecol; 2008 Jun; 47(2):252-5. PubMed ID: 18603524
    [No Abstract]   [Full Text] [Related]  

  • 30. Industry relations with emergency medicine graduate medical education programs.
    Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
    Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Industry has undue influence on academic collaboration and safeguards need strengthening: white coat… which hat.
    Harbin T
    Surv Ophthalmol; 2014; 59(3):346-8. PubMed ID: 24508214
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical practice and pharmaceutical industry: an always difficult relationship].
    Mastai R
    Acta Gastroenterol Latinoam; 2005; 35(4):209-10. PubMed ID: 16496851
    [No Abstract]   [Full Text] [Related]  

  • 33. The pitfalls of misreading: what does "industry funding of medical education" actually say?
    Spielman B
    Am J Bioeth; 2010 Jan; 10(1):24-5. PubMed ID: 20077332
    [No Abstract]   [Full Text] [Related]  

  • 34. Doctors and drug companies.
    Lambert LA
    N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
    [No Abstract]   [Full Text] [Related]  

  • 35. Pens and other pharmaceutical industry gifts.
    Brody H
    Am J Bioeth; 2003; 3(3):58-60. PubMed ID: 14594497
    [No Abstract]   [Full Text] [Related]  

  • 36. The physician's relationship with the pharmaceutical industry: caveat emptor...buyer beware!
    Albersheim SG; Golan A
    Isr Med Assoc J; 2011 Jul; 13(7):389-93. PubMed ID: 21838178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small gifts, conflicts of interest, and the zero-tolerance threshold in medicine.
    Krimsky S
    Am J Bioeth; 2003; 3(3):50-2. PubMed ID: 14594492
    [No Abstract]   [Full Text] [Related]  

  • 38. The AAMC exhibits the behavior it condemns.
    Stossel TP
    Am J Bioeth; 2010 Jan; 10(1):26-7. PubMed ID: 20077333
    [No Abstract]   [Full Text] [Related]  

  • 39. IOM warns about physician-pharma conflicts of interest.
    Landers SJ; O'Reilly KB
    Del Med J; 2009 Jul; 81(7):261-3. PubMed ID: 19902777
    [No Abstract]   [Full Text] [Related]  

  • 40. Medical students protest perks from drug companies.
    Opar A
    Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.